Qilian International Holding Group Limited, a China-based pharmaceutical and chemical products manufacturer, priced its initial public offering late Monday at $5 per American depositary share.The company sold 5,000,000 ordinary shares to raise $25 million from this offering. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The ordinary shares have been approved for listing on the Nasdaq Global Market and are expected to commence trading on January 12, 2021 under the ticker symbol “QLI”.In 2020, Chinese companies held 35 IPOs, raising $12.9 billion, despite a tumultuous year in China-U.S. relations and stricter listing requirements. Mr. Zhanchang Xin, the C

根据世卫组织COVID-19实时更新，全球累计冠状病毒病例超过2亿例，死亡人数超过400万人。德尔塔变种已经在132个国家存在，且近期在美洲和西太平洋地区病例明显增加。 祁连国际控股集团(NASDAQ. QLI)作为一家专业且富有社会责任感的制药企业，在新冠肺炎疫情蔓延全球期间，为了能满足全球对于抗击疫情所需药物之一的刚需——肝素类产品的供给，集团大幅增加了对肝素类产品原料的研发费用和生产投入，在疫情反复、药物愈趋紧缺的情况下，最大限度地支持了肝素原料的生产供给。肝素产品对新冠肺炎重症患者血栓的形成具有一定的恢复作用 据《新冠病毒与血栓》资料显示，在荷兰，法国及海外多家医院对新冠肺炎重症患者的统计中，约有30%的新冠肺炎重症患者出现肺血栓塞病或血液凝块病症。肝素产品对重症新冠肺炎患者血栓的治疗，起到了一定的作用。 肝素钠是粘多糖硫酸酯类抗凝血药物，无法人工合成，主要从健康生猪的小肠粘膜中提取。由于肝素良好的抗凝血作用，被广泛应用于心脑血管手术、关节置换、透析等各类手术和治疗中，是临床首选的抗凝血药物。据媒体报道，此前美国为了应对疫情大流行，曾启动肝素等原料药招标储备。肝素类产品作为目前全球临床抗凝血的原料药，成为了全球抗击疫情的“刚需”，产品的需求日益增大。 肝素出口平均单价创历史新高,肝素概念股开盘大涨 根据海关最新披露数据, 2021年6月肝素出口平均单价为15819.0美元/千克，相比2020年7月4282美元/千克的阶段低点，涨价269%，且超过2010年创下1.1万美元/千克的历史最高价。据新浪财经媒体报道，8月3日肝素概念股开盘大涨，海普瑞、千红制药涨停，常山药业涨超14%，健友股份、东诚药业、红日药业等跟涨。中国肝素原料药产量居世界第一，作为肝素原料主要出口国，肝素原料供应占全球需求量的50%左右。目前海外主要肝素类药物生产厂商包括辉瑞 (NYSE:PFE)、

After China banned banks and payment firms from providing services related to crypto-currency transactions, Bitcoin tumbled as much as 30% to a low of $30,101 on Wednesday morning. Meanwhile, other digital currencies such as Ether, which acts as the fuel for the Ethereum blockchain network, and Dogecoin lost as much as 22% and 24% respectively.Nevertheless, Bitcoin and other cryptocurrencies bounced back within 24 hours, recovering some of yesterday's losses. For example, Bitcoin flirted with the $40,000 level on Thursday, according to Coindesk. The fresh crackdown may make it harder for individuals to buy cryptocurrencies, and the fears of regulatory crackdown could impact miners' business by making it more difficult for them to exchange cryptocurrencies for yuan, but it won't stop crypto

With its low crime rates but high-quality education at an affordable cost, Canada is a natural destination for thousands of international students. Focusing on offering high-quality education resources to students around the globe, a Canada-based private education provider, Visionary Education Technology Holdings Group Inc., today made its debut on Nasdaq under the ticker symbol “VEDU.”The company issued 4,250,000 common shares at a public offering price of US$4.00 per common share, receiving aggregate gross proceeds of US$17 million from the offering. In addition, the company has granted the underwriters a 45-day option to purchase up to an additional 637,500 common shares at the public offering price, less underwriting discounts, and commissions. Headquartered in Markham, Canada, Visiona

Universe Pharmaceuticals, a Chinese medicine manufacturer, updated its S-1 on SEC website, planning to go public on Nasdaq under the ticker symbol “UPC” next week.The Jiangxi, China-based company aims to raise $30 million by offering 5 million shares at a price range of $5 to $7. At the midpoint of the proposed range, Universe Pharmaceuticals would command a market value of approximately $126 million.Founded in 1998, the company specializes in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (“TCMD”) products targeting the elderly with the goal of addressing their physical conditions in the aging process and promoting their general well-being. Universe Pharmaceuticals says in its prospectus that its products are sold in approximately 261 citi

Tesla's stock price skyrocketed 740% in 2020, but the stocks seemed to lose power as soon as reaching a record high of $900 per share in late January. Meanwhile, Tesla's stock price has been dropped 18% to $582 per share for the past eight trading days in May. I am not saying Tesla is not a good and fast-growing company anymore. Tesla is of course a great company run by a great visionary. However, investors are split on whether Tesla is a good investment in 2021 and where the shares will move next.  I can’t predict the stock price, but there are three main headwinds facing Tesla that I think are pertinent to consider today. 1.Inflation concerns are pricking Tech stocks’ bubbles The Labor Department report shows the Consumer Price Index spiked 4.2% from a year ago, the f

Chinese marketing services firm Baosheng Media Group Holdings Limited raised $30 million by offering 6 million shares at a price of $5.00 per ordinary share on Monday. The shares started trading on Nasdaq at around 10:20 a.m. EST under the ticker symbol “BAOS”, surging 81.6% to $9.08.Founded in 2014 in Beijing, BAOS provides marketing solutions, including online marketing strategies, advertising optimization, and delivers online ads such as search ads, in-feed ads, mobile app ads, and social media marketing ads.Last Friday, Kuaishou's stock skyrocketed in value as the TikTok-like video app scored the world's biggest IPO since the coronavirus pandemic began. The Tencent-backed livestreaming platform shows the huge growth potential of short video market in China. Cooperating with Kuaishou, T

Traditional Chinese medicine manufacturer Universe Pharmaceuticals (NASDAQ: UPC) will debut on the Nasdaq Capital Market under the ticker symbol “UPC” on Tuesday, March 23.The China-based company aims to raise $25 million by offering 5 million shares at a price of $5.00 per ordinary share. In addition, Universe Pharmaceuticals has granted its underwriters a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. Based on the company’s SEC filing, proceeds from the offering will be used for upgrading and expanding the Company’s manufacturing facilities, conducting research and development, branding, advertising and marketing, and for working capital and general corporate purposes.Universe Pharmaceuticals was founded in

美国证券交易委员会（SEC）本周披露的文件显示，电影《大空头》原型人物、曾经预测到金融危机的迈克尔-伯里（Michael Burry）在二季度几近抛售所有持股，将其美股投资组合削减至单一资产。伯里的Scion Asset Management披露了超过500000股Geo Group的持股股，价值330万美元。Geo Group投资于私人监狱和心理健康设施，市值不到9亿美元。伯里的追随者们可能会将其最新决策解释为不祥之兆。伯里在去年夏季曾称市场出现了“有史以来最大的投机泡沫”，并表示meme股和加密货币的所有者正朝着“崩盘之母（mother of all crashes）”迈进。他在近期再度告诫投资者，不要对最近的股市反弹过于兴奋，因此市场在触底之前会出现许多暂时性的反弹。他还表示，疫情高峰期间市场的“愚蠢”又回来了，并于周末在社交媒体上称，他“无法摆脱‘9·11’事件、安然和世通丑闻爆发前2001年市况的那种愚蠢的感觉”。伯里几个月来一直在预测美股将暴跌，并削减了其投资组合。他在去年三季度将其投资组合从20家削减至6家，在三个月内将其价值从1.4亿美元降至4200万美元。

According to WHO's COVID-19 live update, the cumulative number of cases worldwide exceeded 200 million, with more than 4 million deaths. The Delta variant has been founded in 132 countries, and now the virus infection cases in the U.S. and Western Pacific keep increasing.In order to meet the global demand for one of the antiviral drugs needed, Qilian International Holding Group (NASDAQ: QLI), a specialized pharmaceutical company with high social responsibility, increases R&D expenses and expands the supply of heparin production during the COVID-19 pandemic. Even when the COVID-19 situation is getting worse and the medicines are in shortage, the Company has ensured that the major heparin manufacturers can have sufficient raw materials for production, and maintain constant supplies to ho

不知不觉2021年已经悄然过半。本周五，叁腾科技在纳斯达克成功上市正式拉开了下半年中概股赴美IPO的序幕。当地时间7月9日上午，上海叁腾科技有限公司的境外控股母公司Sentage Holdings Inc.正式在美国纳斯达克证券交易所挂牌上市，股票代码“SNTG”。此次上市以每股5美元价格发行400万股普通股，筹资2000万美元。上市当天，开盘价冲高至42.99美元，较发行价上涨760%！叁腾科技本次IPO由Network 1 Financial Securities承销。叁腾科技是一家成长中的金融服务提供商，在中国提供包括消费贷款还款和收款管理、贷款推荐、以及预付款网络服务在内的全面金融服务，主要在中国二三线城市开展业务。上市当天，叁腾科技对华尔街多媒体表示，“我们拥有可扩展、可持续的商业模式，配套完善的IT系统和基础设施支持，以及富有经验和远见的管理团队和创新的员工队伍。我们的三块核心业务由集成和互补的产品和服务组合支持。这些使公司在行业中具备一定竞争优势。”财务方面，2020年与2019年叁腾科技的总收入分别为359.54万美元与396.53万美元；同期净利润分别为158.74万美元、183.44万美元；EPS分别为0.16美元和0.18美元。公司表示，上市后将继续投资于技术，专注于人工智能和数据分析，整合三块核心业务联系，建立一个有凝聚力的服务组合，以确保公司的持续盈利能力。另外，据招股书数据披露，2020年、2019年来自消费贷款还款和收款管理的营收分别为107.47万美元、361.88万美元，分别占总营收的29.9%、91.3%。同期，来自贷款推荐服务的营收分别为208.77万美元、26.04万美元，分别占总营收的58.1%、6.6%。不难发现，在过去两年中，公司的主要营收来源正从“消费贷款还款和收款管理”转向“贷款推荐服务”。在这一过程中，既有消费贷款需求激增

两周前刚刚结束的2021年世界精神卫生日的口号是“让人人享有精神卫生保健成为现实”。虽然这一目标或许难以在短时间内实现，但随着全球新冠疫情导致抑郁症患者剧增，人们越发意识到抑郁症的危害以及心理健康的重要性，各国政府和机构也正在加大保护人们心理健康的投入。“预计到2023年，全球抗抑郁药物消费将超过160亿美元！我们将加大对新药研发及医疗技术升级的投资，助力生物医药产业的长期发展，并将持续为全球抑郁症治疗作出贡献。”尚高集团（NASDAQ: SISI）CEO詹妮弗女士说道。全球约10亿人患有精神疾病疫情令抑郁症患者激增就像很多人并不知道每年10月10日是世界精神卫生日一样，抑郁症对一大部分人来说也仍是比较陌生的。当代年轻人习惯性地把“emo”挂在嘴边，似乎并未想象到真正抑郁的严重性。或许有人会觉得身边亲朋好友的“情绪低落”、“悲观厌世“、“烦躁焦虑”是一种不够乐观和无病**的表现，殊不知随着当代生活节奏的加快和竞争压力的加大，以及断断续续的隔离、封锁和学校关闭、工作暂停等的影响，越来越多的抑郁患者就在我们身边。世界卫生组织欧洲区域办事处7月曾表示，新冠疫情对民众的心理健康带来了“长期且深远”的影响，呼吁各国关注并采取应对措施。世卫组织预测，到2030年抑郁症将高居全球疾病负担第一位。最新数据显示，全球大约有10亿人患有精神疾病，其中抑郁症是最为普遍的常见病，估计全世界有3.8%的人口、即约2.8亿人患有不同程度的抑郁症。而这当中，重度抑郁症（MDD）危害最大，患者伴有严重的自杀企图，甚至自杀行为。快速抗抑郁天然创新药获突破性进展尚高并购北京欧纳尔生物目前，对于抑郁症的治疗方式多为药物治疗辅以心理辅导。在药物方面，现有的抗抑郁药物有起效慢、治疗效果有限、副作用明显等缺点。因此不少医药公司都在加大抗抑郁药的研发。值得一提的是，近日该公司研发的天然产物SNG 抗抑郁新机制的动物实验

进入六月，中国公司赴美势头不减。从6月5日开始，达达集团(DADA)、传奇生物(LEGN)和优克联(UCL)三家公司相继在美国纳斯达克上市。此外，上周可能是中国公司在SEC发布招股书最密集的一周。包括燃石医学 (BNR)、声网Agora (API)在内的十多家来自中国的公司已在美国证监会(SEC)递表，并赶着更新招股书，筹备上市。本周纳斯达克上市公司亚洲时代控股有限公司（简称：亚洲时代；Nasdaq股票代码：ATIF）在一周内连续签约爱格丽生物科技有限公司（简称“爱格丽”）以及银富集团（OTC: ELRE，简称“银富”）两家客户，短短几天内营收新增180万美金。这也从侧面反映出，不少优质的中国企业对登陆美国资本市场依旧充满期待。据了解，6月3日亚洲时代与爱格丽在深圳签署了金额为100万美元的赴美上市顾问协议。爱格丽是一家以生物科技为核心技术的国家级高新、高成长性的现代化企业，希望通过国际资本实现国际化发展。此举也标志着爱格丽将受到亚洲时代的助力，正式启动赴美上市计划。亚洲时代的另一家新客户银富已经在美国OTC证券交易所挂牌上市。银富致力于打造中国互联网科技、物联网应用、人工智能行业的旗舰品牌。由于公司业绩持续稳步增长，本着长远发展的角度，公司计划转到主板。在6月11日签下80万美元的咨询服务协议后，亚洲时代将正式担任银富的财务顾问，协助银富进行股权确权和重组、资产和经营模式优化等，强势助力银富未来在纳斯达克或纽交所主板上市。对此，亚洲时代董事长兼首席执行官刘军表示：“我们很荣幸与爱格丽和银富签下服务协议。面对中国公司赴美上市的热情，亚洲时代将发挥我们的专业性和责任心，全力帮助这些优秀企业走进国际市场。期待我们的客户在2020年及以后取得巨大的进步、实现强劲的增长。”亚洲时代是一家以商业、传媒、金融等多方位服务为一体的综合性国际服务集团。主营为企业提供多方位的国际化上市合法合

China-based Shineco, Inc. (NASDAQ: SISI) announced to acquire 51% of the total outstanding equity interest of Xiang Peng You Kang (Beijing) Technology Co., Ltd. ("XPYK") on January 18, 2022. Shineco expects that the acquisition will help it accelerate its digital transformation and develop comprehensive medical and healthcare services, especially digital therapeutics in oncology.Utilizing modern engineering technologies and biotechnologies, Shineco produces, among other products, Chinese herbal medicines, organic agricultural produce, and specialized textiles. At the same time, XPYK is a comprehensive medical and healthcare group with the self-developed "Yikang International Medical and Health Service platform." The platform is an integrated service system with industry-leading medical and

三彩家有限公司（简称“三彩家”），近日已向美国证券交易委员会（SEC）秘密递交招股文件，这意味着三彩家有望成为生活服务产业SaaS系统赴美上市第一股。三彩家有限公司是一家利用大数据、人工智能、移动互联网及LSB等技术，帮助生活服务领域的商户提高人效和服务坪效，降低运营成本，提升用户体验，推动商户数字化升级的科技企业。作为深耕城市服务领域的SaaS综合服务商，三彩家房屋租赁产业SaaS集成了获客、签约、支付、结算、统计、智能识别、定位等关键技术，历经迭代升级，已为房屋租赁企业构建了一套完整的应用平台，包含三彩家APP、智慧管理云APP、智慧管理云PC，小程序和服务号，吸引了众多不动产管理公司、房屋租赁公司、房产中介公司、公寓公司等入驻。目前，三彩家已覆盖全国24个重点发展城市，线上房源量已达5万+，累计服务用户超过20万人。有数据显示，三彩家房屋租赁产业SaaS依托自主开发的获客、交易结算、客户管理、员工管理、房源管理、数据分析、供应链服务七大系统，围绕“人”“财”“物”，使房屋租赁产业商户出房效率提升320%，房屋空置率降低了76%，存房风险降低81%，员工产能提升3.2倍，利润率提升了25%，为房屋租赁产业商户实现了"赋能"和"增效"。据了解，截止2019年12月，三彩家月交易额已突破1亿人民币。预计2020年交易额突破100亿，2021年交易额突破1000亿。三彩家将利用在房屋租赁产业的经验，在2020年复制到家政服务产业、社区物业管理产业。今年突如其来的疫情使得房屋租赁行业经历了史上最严峻的“大考”，租客减少，租金下降，个卡收款从严监管，成本持续加重，不少房屋租赁企业苦苦支撑，然而这为房企线上业务渠道拓展带来了新的契机，激发了大量的房企把线下业务搬到线上运营。三彩家联合创始人兼CTO费欣伟曾在第三届“寓言·未来”住房租赁产业高峰论坛时表示，“当公寓体量越大，企业面临的